Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Quidel revenue
Quidel's revenue is $1.7 billion.
What is Quidel's revenue?
- Quidel's revenue growth from 1999 to 2021 is 2,905.27%.
- Quidel has 1,500 employees, and the revenue per employee ratio is $1,132,367.
- Quidel's peak quarterly revenue was $1.0B in 2022(q1).
- Quidel peak revenue was $1.7B in 2021.
- Quidel annual revenue for 2020 was 1.7B, 210.66% growth from 2019.
- Quidel annual revenue for 2021 was 1.7B, 2.22% growth from 2020.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Quidel historical revenue
Quidel's peak revenue was $1.7B in 2021. The peak quarterly revenue was $1.0B in 2022(q1).
Quidel's revenue increased from $56.5m in 1999 to $1.7B currently. That's a 2,905.27% change in annual revenue.
Quidel annual revenue
Quidel annual revenue over time
| Fiscal year / year | Quidel revenue |
|---|---|
| 2009 | $164.3M |
| 2010 | $113.3M |
| 2011 | $158.6M |
| 2012 | $155.7M |
| 2013 | $177.3M |
| 2014 | $184.2M |
| 2015 | $196.1M |
| 2016 | $191.6M |
| 2017 | $277.7M |
| 2018 | $522.3M |
| 2019 | $534.9M |
| 2020 | $1.7B |
| 2021 | $1.7B |
How accurately did Quidel's revenue projections match actual performance?
Quidel annual growth
Quidel saw the greatest revenue growth in 2020, when revenue increased by 210.66%.
Quidel had the lowest revenue growth in 2010, when revenue changed by -31.01%.
Quidel annual growth rate over time
| Year | Quidel growth |
|---|---|
| 2009 | 28%↑ |
| 2010 | -31%↓ |
| 2011 | 40%↑ |
| 2012 | -2%↓ |
| 2013 | 14%↑ |
| 2014 | 4%↑ |
| 2015 | 7%↑ |
| 2016 | -2%↓ |
| 2017 | 45%↑ |
| 2018 | 88%↑ |
| 2019 | 2%↑ |
| 2020 | 211%↑ |
| 2021 | 2%↑ |
Quidel quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Quidel quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $16.9M | $24.6M | $56.2M | $66.6M |
| 2010 | $28.4M | $25.0M | $28.2M | $31.7M |
| 2011 | $59.6M | $27.5M | $33.1M | $38.4M |
| 2012 | $38.0M | $30.9M | $33.0M | $53.9M |
| 2013 | $62.0M | $29.7M | $33.5M | $52.1M |
| 2014 | $46.7M | $31.5M | $41.2M | $64.0M |
| 2015 | $61.7M | $35.2M | $46.8M | $52.4M |
| 2016 | $50.3M | $39.1M | $49.3M | $52.8M |
| 2017 | $73.7M | $38.3M | $50.9M | $114.9M |
| 2018 | $169.1M | $103.2M | $117.4M | $132.6M |
| 2019 | $148.0M | $108.3M | $126.5M | $152.2M |
| 2020 | $174.7M | $201.8M | $476.1M | $809.2M |
| 2021 | $375.3M | $176.6M | $509.7M | $636.9M |
| 2022 | $1.0B | - | - | - |
Quidel jobs nearby
Do you work at Quidel?
Did Quidel meet its revenue projections?
Quidel financial information
| CEO | Douglas C. Bryant |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 1,500 |
| Date Founded | 1979 |
| Headquarters | San Diego, California |
| Number of Locations | 3 |
| Revenue | $1.7B |
| Net Income | $704,226,000 |
| Gross Proft | $1.3B (2021) |
| EBITDA | $18.4M (2011) |
| PE Ratio | 3.23 |
| Tax Rate | 0.2% |
| Market Capitalization | $2.3B |
| Total Assets | $2,430,374,000 |
| Ticker | QDEL |
Quidel jobs you might like
Quidel financing
Quidel received early financing of $0.0 on 2020-06-11.
| Series | Round size | Date |
|---|---|---|
| Grant - Quidel | 06/2020 |
Quidel investors
| Investors | Security type |
|---|---|
| Biomedical Advanced Research and Development Authority (BARDA) | Grant - Quidel |
Quidel competitors
Quidel's top competitor, Merck, earned an annual revenue of $64.2B.
Quidel's smallest competitor is Cambridge Major Laboratories, Inc. with revenue of $17.0M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | $90,328 | $64.2B | 74,000 | 1,607 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 272 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 639 |
| Zoetis | $87,092 | $9.3B | 11,300 | 280 |
| Cubist Pharmaceuticals | $91,725 | $926.4M | 873 | - |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Regeneron | $85,589 | $14.2B | 9,123 | 379 |
| Seagen | $85,008 | $2.0B | 900 | - |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Medivation | $94,135 | $1.0B | 628 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Quidel highest paying jobs
Zippia gives an in-depth look into the details of Quidel, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Quidel. The employee data is based on information from people who have self-reported their past or current employments at Quidel. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Quidel. The data presented on this page does not represent the view of Quidel and its employees or that of Zippia.
Quidel may also be known as or be related to QUIDEL CORP DE, Quidel, Quidel Corp. and Quidel Corporation.